HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
CompletedNCT00864825

Allopurinol added to antipsychotics for schizophrenia

About this titleRead the official source — NCT00864825
Medication studyAges 18–65Israel + Romania
The study in practice

Understand this study

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
Bat Yam and 32 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateAugust 2009
Recruitment status
Completed
Enrollment listed in the registry
248
Sponsor
Sheba Medical Center
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Israel, Romania
Age range
From 18 Years to 65 Years
Official registry ID
NCT00864825
Official title
Show the full official title

Allopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With Schizophrenia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Bat Yam, Israel · Beer-Yaakov, Israel · Hod HaSharon, Israel

23 more locations
  • Jaffa, Israel
  • Jerusalem, Israel
  • Ness Ziona, Israel
  • Shaar Menashe, Israel
  • Tel Hashomer, Ramat Gan, Israel
  • Tsur Moshe, Israel
  • Bd. Iosif Bulbuca, 156, Jud Timis, Romania
  • Berceni St., 10-12, Bucharest, Romania
  • Berceni St., 10-12, Sector 4, Bucharest, Romania
  • Berceni St., Sector 4 Bucharest, Romania
  • Bld Nicolae Grigorescu, No. 41, Sector 3,, Romania
  • Bucuresti, Mircea Vulcanescu 88, Str. Vulcanescu, Nr. 88, Romania
  • Cuza Voda St, 36, Oradea, Romania
  • Gh. Marinescu St.38 ,Targu-Mures, Romania
  • Octavian Goga St, 17, Arad, Romania
  • Sos Bucium, 36, Iasi, Romania
  • Sos. Stefan Cel Mare Nr. 19-21, Sect. 2, Romania
  • Str. Bagdazar 12, Sibiu, Romania
  • Str. Clinicilor Nr. 3-5, 3400, Romania
  • Str. I.C.Bratianu Nr. 116, Botosani, Romania
  • Str. Prundului 7 - 9, Brasov, Romania
  • Str. Victor Babes, Nr. 43, Cluj Napoca, Romania
  • Str.Mihai Eminescu, Nr.18, Brasov, Romania
Checked Official study record (opens in a new tab)
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Sheba Medical Center, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Allopurinol.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies